AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04658095 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: iStent inject
Description: Ab-interno implantation of iStent inject (2 microstents)
Study NCT04658095 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: OMNI® Surgical System
Description: Ab-interno canaloplasty (360 degrees) using the OMNI Surgical System
Study NCT05497674 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rongliflozin
Description: oral administration, single dose on Day 1 and Day 11
Study NCT05497674 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rifampin
Description: QD for 10 days
Study NCT05497674 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rongliflozin
Description: oral administration, single dose on Day 1 and Day 6
Study NCT05497674 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Probenecid
Description: twice a day, for 5 days
Study NCT05743075 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo solution
Study NCT06224660 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: SRD-001
Description: SRD-001 is an adeno-associated virus serotype 1 (AAV1) based gene therapy designed to deliver a copy of the gene encoding the human sarcoplasmic/endoplasmic reticulum Ca(2+) ATPase 2a (SERCA2a). It is administered as a one-time intracoronary infusion.
Study NCT06459843 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pursed lip breathing techniques
Description: Relax your neck and shoulder muscles. For the use of PLB exercise, the intervention will be given every day till the patient discharged from hospital. Patient will perform 5 sets. In each set, 10 times will be included. Then, instruct the patient to take deep breath through nose for two counts, and keep mouth closed. Inhale for 2 seconds. Now, ask the patient to purse the lips as if the patient was going to gently flicker the flame of candle. Now the patient will breathe out gently while counting for 4 seconds.
Study NCT06459843 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: coordinated breathing technique
Description: Put one hand on your abdomen. Make your abdomen push out while you breathe in through your nose. Suck in your abdominal muscles. Breathe out using the pursed-lip technique. You should feel your abdomen go down. Repeat three times and rest for two minutes.
Study NCT04583254 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: External beam radiotherapy (EBRT) + High-dose rate (HDR) Brachytherapy Experimental
Description: 40 Gy / 15 Fractions EBRT + HDR-Brachytherapy
Study NCT04813991 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ibuprofen 600 mg
Description: Ibuprofen 600 mg for breakthrough pain.
Study NCT04813991 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: OxyCODONE 5 Mg Oral Capsule
Description: OxyCODONE 5 Mg Oral Capsule for breakthrough pain.
Study NCT04583254 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: External beam radiotherapy (EBRT) + High-dose rate (HDR) Brachytherapy Standard of Care
Description: 45 Gy / 25 Fractions EBRT + HDR-Brachytherapy
Study NCT04583254 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Concurrent Chemotherapy
Description: Weekly cisplatin 40 mg/m2 for a maximum of 5 cycles
Study NCT04583254 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Concurrent Chemotherapy
Description: Weekly cisplatin 40 mg/m2 for a maximum of 5 cycles
Study NCT04697186 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Berberine
Description: berberine , amoxicillin and rabeprazole triple therapy group: given for 14 days at a dose of berberine 100 mg 3 tablets TID, amoxicillin 500 mg 2 capsules BID ，rabeprazole 10 mg BID.
Study NCT04697186 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amoxicillin
Description: berberine , amoxicillin and rabeprazole triple therapy group: given for 14 days at a dose of berberine 100 mg 3 tablets TID, amoxicillin 500 mg 2 capsules BID ，rabeprazole 10 mg BID.
Study NCT04697186 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rabeprazole
Description: berberine , amoxicillin and rabeprazole triple therapy group: given for 14 days at a dose of berberine 100 mg 3 tablets TID, amoxicillin 500 mg 2 capsules BID ，rabeprazole 10 mg BID.
Study NCT04697186 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Amoxicillin
Description: Bismuth-containing Quadruple Therapygroup: given for 14 days at a dose of amoxicillin 500 mg 2 capsules BID ，clarithromycin 500mg BID ,rabeprazole 10 mg BID and bismuth 110 mg 2 capsules BID
Study NCT04697186 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Clarithromycin
Description: Bismuth-containing Quadruple Therapygroup: given for 14 days at a dose of amoxicillin 500 mg 2 capsules BID ，clarithromycin 500mg BID ,rabeprazole 10 mg BID and bismuth 110 mg 2 capsules BID
Study NCT04697186 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rabeprazole
Description: Bismuth-containing Quadruple Therapygroup: given for 14 days at a dose of amoxicillin 500 mg 2 capsules BID ，clarithromycin 500mg BID ,rabeprazole 10 mg BID and bismuth 110 mg 2 capsules BID
Study NCT04697186 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bismuth
Description: Bismuth-containing Quadruple Therapygroup: given for 14 days at a dose of amoxicillin 500 mg 2 capsules BID ，clarithromycin 500mg BID ,rabeprazole 10 mg BID and bismuth 110 mg 2 capsules BID
Study NCT05753930 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Imlifidase
Description: Imlifidase is an immunoglobulin G (IgG)-degrading enzyme of Streptococcus pyogenes that is highly selective towards IgG. The cleavage of IgG generates one F(ab')2- and one homodimeric Fc-fragment and efficiently neutralizes Fc-mediated activities of IgG.
Study NCT04855097 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: BVA-100
Description: The BVA-100 is a medical device that calculates human blood volume using the method of tracer dilution. The device utilizes a tracer of human serum albumin tagged with iodine-131 to measure injected intravascularly and a series of timed blood draws. The amount of tracer in each blood draw is used to calculate the unknown blood volume. Data inputs come from the measured characteristics of subject blood samples (hematocrit and tracer concentration) and tracer calibration standards. The package also calculates the subject expected (or ideal) blood volume from physical parameters. Hyper- or hypovolemia, associated red blood cell volumes, and tracer transudation rate are reported, with statistics showing the quality of the results.
Study NCT06034067 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Osseodensification osteotomy preparation
Description: The implant site will be prepared by raising a mucoperiosteal flap. Implant osteotomy will be prepared by using osseodensification technique using Versah burs and a dental implant will be placed. The flaps will then be replaced and sutured with 4/0 polyglycolic acid interrupted and mattress sutures.
Study NCT06034067 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standardized osteotomy preparation
Description: The implant site will be prepared by raising a mucoperiosteal flap. Implant osteotomy will be prepared by using either conventional surgical drills provided by Straumann implant systems and a dental implant will be placed. The flaps will then be replaced and sutured with 4/0 polyglycolic acid interrupted and mattress sutures.
Study NCT06469866 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: low-pressure pneumoperitoneum
Description: low-pressure pneumoperitoneum (LPP) with deep NMB.
Study NCT05042258 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dupilumab
Description: 12 week dupilumab administration
Study NCT06469866 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: standard-pressure pneumoperitoneum
Description: standard-pressure pneumoperitoneum (SPP) with moderate NMB.
Study NCT04824885 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Chlorhydric acid based acid concentrate for bicarbonate hemodialysis (medical device)
Description: usual dialysate (A + D) for 6 months and then switch to A-D dialysate for the next 6 months
Study NCT05741008 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Target range
Description: Compared with conventional radiotherapy, the target dose is unchanged and the CTV2 volume is reduced.
Study NCT05744453 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Olive Leaf Extract
Description: experimental arm
Study NCT05744453 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Cellulose
Description: placebo comparator arm
Study NCT06223386 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Designed on-line course A with 3-month consultation with the dietitian
Description: Educational materials on weight reduction will be provided at the beginning of the 3-month intervention. Participants can consult with the dietitian via the APP on their mobile phones during the intervention period. These materials will encompass dietary and physical activity guidelines by the government in Taiwan.
Study NCT06223386 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Designed on-line course B with 3-month consultation with the dietitian
Description: Educational materials on weight reduction will be provided every weekday for 8 weeks. Participants can consult with the dietitian via the APP on their mobile phones during the 3-month intervention period. These materials will encompass various aspects such as dietary habits, physical activity, and daily routines, all designed to impart online lifestyle education.
Study NCT06223386 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Designed on-line course B with 3-month consultation with the dietitians + 3-month daily dietary assessment by the dietitians
Description: Educational materials on weight reduction will be provided every weekday for 8 weeks. Participants can consult with the dietitian via the APP on their mobile phones during the 3-month intervention period. These materials will encompass various aspects such as dietary habits, physical activity, and daily routines, all designed to impart online lifestyle education. In addition, dietitians assess participants' daily diet for 3 months.
Study NCT06223386 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Designed on-line course B with 6-month consultation with the dietitians + 6-month daily dietary assessment by the dietitians
Description: Educational materials on weight reduction will be provided every weekday for 8 weeks. Participants can consult with the dietitian via the APP on their mobile phones during the 6-month intervention period. These materials will encompass various aspects such as dietary habits, physical activity, and daily routines, all designed to impart online lifestyle education. In addition, dietitians assess participants' daily diet for 6 months.
Study NCT05158088 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Borescope
Description: Endotracheal intubation using borescope
Study NCT05158088 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Video laryngoscope
Description: Endotracheal intubation using video laryngoscope
Study NCT04693416 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intrapersonal Stigma Reduction
Description: Brief intervention for stigma reduction
Study NCT04693416 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Interpersonal Stigma Reduction
Description: Brief intervention for support persons of intrapersonal intervention participants.
Study NCT05213039 — intervention group
Intervention type: OTHER
Intervention: assessments
Description: All of the children with cerebral palsy will be assessed by two different physiotherapist observers. The timed 360° turn test, Expanded and revised Gross Motor Function Classification System (GMFCS-E\&R) for functional motor levels of the subjects, lower extremity muscle tone will be measured with the Modified Ashworth Scale (MASH) at the beginning of the one-time study and recorded. Pediatric Berg Balance Scale, Timed Up and Go Test, Pediatric Functional Reaching test and Modified Four Square Stepping Test, 3m walking back test (3MGYT) will be performed.Evaluations will be made by two separate physiotherapists with at least 5 years of experience in this field. The time it took for individuals to complete activities during the tests with a stopwatch will be recorded.
Study NCT05223881 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 13^C Spirulina Platensis Gastric Emptying Breath Test (GEBT)
Description: After an overnight (minimum 8 hours) fast, patients are given a standardized test meal, after which they are administered the GEBT. Patients are asked to hold a glass tube in a comfortable position, take a deep breath and pause momentarily, blow gently into the tube for 5 - 10 seconds, slowly withdraw straw from tube while continuing to breath into tube, and immediately close the tube securely with the cap.
Study NCT05223881 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 13^C Spirulina Platensis Gastric Emptying Breath Test (GEBT)
Description: After an overnight (minimum 8 hours) fast, patients are given a standardized test meal, after which they are administered the GEBT. Patients are asked to hold a glass tube in a comfortable position, take a deep breath and pause momentarily, blow gently into the tube for 5 - 10 seconds, slowly withdraw straw from tube while continuing to breath into tube, and immediately close the tube securely with the cap.
Study NCT05108090 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: sentinel lymph node biopsy (SLNB)
Description: Preoperative Lymphoscintigraphy: A standard injection of 2 mCi of 99m-Technetium sulfur colloid. Sequential immediate and delayed images will be obtained using SPECT/CT using a gamma probe. Ten-second counts will be done in areas of high activity to identify location of sentinel lymph node (SLN). After removal of the lymph node, a 10-second count will be done of the lymph node ex-vivo followed by 10-second count of the lymph node resection bed to ensure removal of SLN (less than 10% activity of LN).~Surgical resection: Mohs micrographic surgery followed by SLNB. Intraoperative margins around the tumor will be confirmed through frozen section analysis. Patients with planned free flap reconstruction, will undergo SLNB with intraoperative, frozen section analysis. If lymph node is positive, immediate completion neck dissection will occur.
Study NCT05093543 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: physical rehabilitation/physiotherapy and psychosocial group sessions
Description: physical rehabilitation/physiotherapy and psychosocial group sessions
Study NCT05315427 — intervention group
Intervention type: OTHER
Intervention: one music therapy session
Description: Edmonton Symptom Assessment System (ESAS) scale (before and after music therapy session), Numerical pain scale (before and after music therapy session)
Study NCT06176014 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: implant placement
Description: 5 implant were placed in intraforaminal area using surgical guide
Study NCT06467110 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: transcatheter mitral valve clip delivery system and steerable guide catheter (Shenqi Medical)
Description: The principle of this product is the transcatheter interventional edge-to-edge repair technology (edge-to-edge repair). The core technology is to treat the regurgitation by edge-to-edge suturing the mitral valve. The double holes are set in the mitral valve (A2/P2 zone) or the edges in A1/P1 or A3/P3 zones are apposed and closed to treat regurgitation.
Study NCT06346652 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Routine Physical Therapy
Description: Routine physical therapy involving muscle strengthening exercises, range of motion exercises and stretching exercises up to patient's tolerance. Other exercises were pelvic bridging, rolling, sitting and standing exercises, walking practice and balancing in parallel bars, wobble board exercises. Each session was of 60 minutes 5 times weekly for 6 weeks.
Study NCT06346652 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Routine Physical Therapy+ PNF and Core Stregthening
Description: Routine physical therapy for 20 minutes and additionally PNF technique (rhythmic initiation, and then agonistic reversals were performed in lower extremity in D1 flexion pattern and D1 extension pattern up to patient's tolerance and core strengthening for 20 minutes 5 times weekly for 6 weeks.
Study NCT05046743 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Colonic gas load
Description: Colonic infusion of gas via an anal cannula
Study NCT05046743 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham load
Description: Sham infusion of gas via an anal cannula
Study NCT05931978 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CKD dashboard
Description: Online dashboard that visualizes patients' individual PROM- and clinical data related to their kidney disease.
Study NCT06451211 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab
Description: Tislelizumab 200 mg will be administered systemically on day 1 of each cycle in all participants
Study NCT06451211 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Description: Oxaliplatin 150 mg will be administered systemically on day 1 of each cycle in all participants
Study NCT06493708 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Trauma focused psychotherapy: EMDR
Description: 14 sessions of psychotherapy with EMDR will be carried out with patients. One session per week, lasting 90 minutes. The first two sessions will be used for the description of the EMDR method and for stabilization, then there will be treatment sessions.
Study NCT05814887 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ReLink
Description: Medical device
Study NCT06451211 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: S-1
Description: S-1 40 mg will be administered orally on day 1-14 of each cycle in all participants
Study NCT06404606 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Black cumin and turmeric with Quantum Acoustic Waves (QAW)
Description: Black cumin and turmeric are known to be helpful in reduction of inflammation of human body so it will be used in combination with Quantum Acoustic Waves (QAW) to determine effects on initial degenerative changes in osteoarthritis.
Study NCT06451211 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: Capecitabine 2500 mg will be administered orally on day 1-14 of each cycle in all participants
Study NCT05543876 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: suturing procedure
Description: Children presenting to the emergency department for suturing
Study NCT05810792 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Histamine Dihydrochloride (HDC)
Description: HDC is administrated in combination with IL-2 as peri- and post-operative treatment in patients undergoing surgery. 0.5 mg HDC is administered twice daily by subcutaneous injections 1 to 3 minutes after each IL-2 injection during three 3 week cycles, with 3-week resting periods inbetween. The first treatment cycle is initated 2 weeks prior to surgery, with an additional 2-3 days rest period during the surgical procedure, before the third treatment week is initiated.
Study NCT05810792 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Interleukin-2 (IL-2)
Description: IL-2 is administrated in combination with HDC during three 3 week cycles as peri- and post-operative treatment in patients undergoing surgery. IL-2 is administered twice daily as a subcutaneous injection 1 to 3 minutes prior to the administration of histamine dihydrochloride; each dose of IL-2 is 16,400 IU/kg (1µg/kg).
Study NCT05785260 — intervention group
Intervention type: BEHAVIORAL
Intervention: ACT MINDFULNESS
Description: Mindfulness (MCBT) practices were offered to patients with the aim of fostering the elderly's pro-active role in health prevention by making them~aware of the relationship between thoughts, emotions and symptomatology of the disorder. The exercises will also be used as a motivational work tool within a protocol of Acceptance and Commitment Therapy (ACT), a new generation cognitive behavioral approach, in which commitment components are added to mindfulness, suitable for lifestyle modification.
Study NCT05304143 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Immersive Reality Glasses
Description: The day of the examination, the patient will go to the MRI room and he will be fitted with virtual reality glasses compatible with the MRI equipment. The patient will visualize relaxing contents in open spaces with music and verbal instructions during all the procedure. The contents will be previously validated by the clinical psychologist of the center with experience in this regard.~During the test, the patient's heart rate will be monitored.
Study NCT05304143 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional nurse support
Description: Patients will be treated using the usual support technique to reduce anxiety in the Diagnostic Imaging service
Study NCT05295823 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Butterfly portable ultrasound device with bladder ultrasound images
Description: Point-of-care PVR measurement using existing ultrasound technology (3 consecutive measurements during the same encounter) the Butterfly portable ultrasound device with bladder ultrasound images
Study NCT05295823 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Butterfly portable ultrasound device with abstract bladder images
Description: Point-of-care PVR measurement using the Butterfly portable ultrasound device with abstract bladder images